Biocytogen Pharmaceuticals Beijing Co. Ltd. has announced a voluntary share repurchase and the establishment of a trust as part of a share award scheme. The company has emphasized that the repurchase of shares is subject to market conditions and will be executed at the discretion of the Board. Shareholders and potential investors are advised to exercise caution when dealing with the shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.